2024 Glyco-Immunology Webinar Series

Program Overview

The 2024 Glyco-Immunology Webinar Series consists of three free, two-hour public webinars that feature expert invited speakers and attendee question and answer periods. This series will highlight exciting questions and opportunities in the field of glyco-immunology, an emerging area within the field of immuno-oncology.

Problem Statement
With the recent development of new tools, researchers are now able to assess the role of tumor glycans on anti-tumor immunity and immune resistance. Despite its great potential to advance clinical and translational aspects of cancer immunotherapy, there is a marked lack of education and awareness within the field of immuno-oncology on glycobiology and its connection with the immune system, and the field of glyco-immunology remains largely nascent. The scientific community must effectively address and develop the field of glyco-immunology, generating more effective cancer immunotherapies and improving patient outcomes.

Series Goals and Learning Objectives
The primary objective of the SITC SfG Glyco-Immunology Webinar Series is to highlight clinical and translational opportunities and challenges in the field of glyco-immunology. Secondary goals and learning objectives include:

  • Defining the impact of glycans on anti-tumor immunity and immune resistance
  • Applying principles of glyco-immunology to develop more effective cancer immunotherapies
  • Establishing SITC as a home for researchers and healthcare providers interested in glyco-immunology and cancer immunotherapy.

Program Schedule

Webinar 1: Introduction to Glyco-Immunology

July 11, 2024 | 11 a.m.–1 p.m. EDT

Webinar 1: Introduction to Glyco-Immunology
Presentation

Faculty

Introduction to Tumor-Associated Glycans and Their Functional Roles in Tumor Immunity

Susan Bellis, PhD – University of Alabama, Birmingham

Glycans at the Interface of Innate and Adaptive Immunity

Brian Cobb, PhD – Case Western Reserve University

Webinar 2: Glycocheckpoints

Aug. 8, 2024 | 11 a.m.–1 p.m. EDT

Webinar 2: Glycocheckpoints
Presentation

Faculty

The Siglec-Sialoglycan Axis in Tumor Immunity and Therapy Resistance

Heinz Läubli, MD, PhD – University of Basel

The Galectin-Glycan Axis in Tumor Immunity and Immune Resistance

Gabriel A. Rabinovich, PhD – University of Buenos Aires

Webinar 3: Glycan Biology Playing a Role in Tx Approaches for T-cell Directed Tx

Sept. 10, 2024 | 11 a.m.–1 p.m. EDT

Webinar 3: Glycan biology playing a role in Tx approaches for T-cell directed Tx
Presentation

Faculty

Glycosylation and Immune Checkpoint Pathways

Stacy Malaker, PhD – Yale University

Adoptive T-cell Therapies and Other Glycan Related Therapies

Avery Posey, Jr., PhD – University of Pennsylvania

Organizer and Faculty

David Feltquate, MD, PhD - Palleon Pharmaceuticals 

Organizer
David Feltquate, MD, PhD

Palleon Pharmaceuticals 

Susan Bellis, PhD - University of Alabama

Faculty
Susan Bellis, PhD

University of Alabama, Birmingham

Brian Cobb, PhD - Case Western Reserve University

Faculty
Brian Cobb, PhD

Case Western Reserve University

Heinz Läubli, PhD - University of Basel 

Faculty
Heinz Läubli, MD, PhD

University of Basel 

Stacy Malaker, PhD - Yale University

Faculty
Stacy Malaker, PhD

Yale University

Avery Posey, PhD - University of Pennsylvania

Faculty
Avery Posey, Jr., PhD

University of Pennsylvania

Gabriel A. Rabinovich - University of Buenos Aires 

Faculty
Gabriel A. Rabinovich, PhD

University of Buenos Aires